Cugene is a clinical-stage biotechnology company focused on developing next-generation precision immunology and oncology medicines that harness specific immune cells to treat autoimmune disease and cancer.
| Website | https://www.cugene.com |
| Revenue | $5 million |
| Employees | 17 (14 on RocketReach) |
| Founded | 2016 |
| Address | 130 Turner Street Suite 702, Waltham, Massachusetts 02453, US |
| Phone | +1 614-777-1000 |
| Technologies |
JavaScript
,
HTML
,
PHP
+11 more
(view full list)
|
| Industry | Biotechnology Research, Business Services General, Business Services |
| Keywords | Biotechnology, Oncology Medicines, Cancer Treatment, Clinical Stage, Drug Development, Immunotherapy, Targeted Therapy, Cell Therapy, Biopharma, Pharmaceutical, Research, Development, Therapeutics, Biologics, Healthcare, Medicine, Clinical Trials |
| Competitors | Roche, Novartis, Pfizer, AstraZeneca, Bristol Myers Squibb, Amgen, Gilead Sciences, Vertex Pharmaceuticals, Biogen, Lilly India +37 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular Cugene Inc. employee's phone or email?
The Cugene Inc. annual revenue was $5 million in 2026.
Jing Xu is the EVP of Research and Development of Cugene Inc..
14 people are employed at Cugene Inc..
Cugene Inc. is based in Waltham, Massachusetts.
The NAICS codes for Cugene Inc. are [32541, 325, 3254, 32].
The SIC codes for Cugene Inc. are [28, 283].